MSD unveils its Dublin biotech facility.

The Taoiseach, Micheál Martin, and Robert M. Davis, MSD’s global CEO and president, officially opened MSD Ireland’s new production facility at MSD Biotech in Swords, Co. Dublin.

Since construction on the biotech facility started in 2018, the healthcare business has invested more than €1 billion in it, and it is already essential to the production of MSD’s biologics-based medications, such as immuno-oncology.

There are now 70 unfilled opportunities, and 350 new jobs have been created since the establishment of the new location.

The pharmaceutical company has six locations in Ireland and has been operating there for many years. Approximately 3,000 employees work there. The pharmaceutical giant has just made almost $4 billion in its Irish operations.

In August of this year, MSD announced that as part of a significant expansion of its Carlow plant, it would add 100 new employees.

We use cookies to give you the best online experience. By agreeing you consent the use of cookies in accordance with our Privacy Statement and cookie settings in your Privacy Settings below.

Privacy Settings saved!
Privacy Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie

Decline all Services
Accept all Services